Report: Biosimilars Drive Down Prices of Biologics
...
Top Story
Featured Stories
Report: Biosimilars Drive Down Prices of Biologics
A recent study published in JAMA Network Open suggests biologics filgrastim, pegfilgrastim, infliximab and insulin… Read more
CMS Chief Talks Health Policy, 'Medicare for All' Proposals
Centers for Medicare and Medicaid Services Administrator Seema Verma sat down with Kaiser Health News to discuss the… Read more
Gorenstein's New Podcast Explores Health System
A new podcast produced by veteran health care journalist Dan Gorenstein, Tradeoffs, explores an "often counterintuitive… Read more
Latest Stories
Report: Biosimilars Drive Down Prices of Biologics
A recent study published in JAMA Network Open suggests biologics filgrastim, pegfilgrastim, infliximab and insulin glargine all saw their prices drop in response to biosimilar competition. The study by University of Pittsburgh School of Pharmacy's Alvaro San-Juan-Rodriguez et al. analyzed pricing […]
CMS Chief Talks Health Policy, ‘Medicare for All’ Proposals
Centers for Medicare and Medicaid Services Administrator Seema Verma sat down with Kaiser Health News to discuss the administration's roadmap for public health insurance programs and new "Medicare for All" proposals. KHN's Sarah Varney asked Verma about the Medicaid enrollment process, and […]
Gorenstein’s New Podcast Explores Health System
A new podcast produced by veteran health care journalist Dan Gorenstein, Tradeoffs, explores an "often counterintuitive health care system." According to a Health Affairs blog post, the Robert Wood Johnson Foundation and California Health Care Foundation funded part of the podcast's first season, […]
Lilly Exec Talks Insulin Market
Pharmalot recently caught up with Mike Mason, head of Eli Lilly's diabetes branch, to discuss the drugmaker's generic alternative to its Humalog insulin, LisPro. Lilly offers LisPro at half the price of Humalog, $137.35 per vial. While two senators in December issued a report suggesting the […]
KHN: Sanders Claim on Profits in Health Industry Checks Out
Sen. Bernie Sanders during the recent Democratic debate said "Medicare for All" has the power to "end the $100 billion a year that the health care industry makes." Kaiser Health News says the math checks out. Experts tell KHN the $100 billion figure is likely an underestimate. According to the […]
Kellogg’s Garthwaite Outlines Key Hurdles to Medicare for All
Kellogg School of Management's Craig Garthwaite and colleagues in a recent paper outlined some key challenges to Medicare for All, including labor costs and drug prices. The paper, "The Opportunities and Limitations of Monopsony Power in Healthcare: Evidence from the United States and Canada," […]
Report: Pharma Companies Want Lower Drug Prices, but Don’t Want to Lower Their Own
While pharma executives were making their proposals for lower drug prices during the J.P. Morgan Healthcare Conference, none were willing to cut their own prices, CNBC reports. According to the report, executives brought with them a host of proposals, including changes to Medicare and passing off […]
CMS Chief Talks Drug Prices at Event
Centers for Medicare and Medicaid Services (CMS) Administrator Seema Verma during this year's J.P. Morgan Health Care Conference doubled down on the administration's proposal to align Medicare Part B drug prices with international prices, Barron's reports. "People feel like it's not fair to our […]
AMCP Plans Webinar on Format for Formulary Submissions
The Academy of Managed Care Pharmacy (AMCP) is slated to host a webinar 2 p.m. EST Jan. 23 regarding updates to the AMCP Format for Formulary Submissions. The latest version of the guidance, version 4.1, was published in December. "The new guidance represents a substantial step forward in […]
Concerto HealthAI Announces Funding, Partnerships at J.P. Morgan Conference
Concerto HealthAI during the J.P. Morgan Healthcare Conference announced it had secured $150 million in a new round of funding and launched two real-world data collaborations with pharmaceutical companies, FierceBiotech reports. Concerto also debuted its new real-world data platform, eurekaHealth […]
